Lukasz Tekieli

Dr. Lukasz Tekieli


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AMAdam Mazurek
Adam Mazurek
KMKrzysztof Piotr Malinowski
Krzysztof Piotr Malinowski
KRKenneth Rosenfield
Kenneth Rosenfield
LCLaura Capoccia
Laura Capoccia
FSFrancesco Speziale
Francesco Speziale
PMPiotr Musiałek
Piotr Musiałek
Background: Single-cohort studies suggest that second-generation stents (SGS; “mesh stents”) may improve carotid artery stenting (CAS) outcomes by limiting peri- and postprocedural cerebral embolism. SGS differ in the stent frame construction, mesh material, and design, as well as in mesh-to-frame position (inside/outside). Objectives: To compare clinical outcomes of SGS in relation to first-generation stents (FGSs; single-layer) in CAS. Methods: We performed a systematic review and meta-analysis of clinical studies with FGSs and SGS (PRISMA methodology, 3302 records). Endpoints were 30-day death, stroke, myocardial infarction (DSM), and 12-month ipsilateral stroke (IS) and restenosis (ISR). A random-effect model was applied. Results: Data of 68,422 patients from 112 eligible studies (68.2% men, 44.9% symptomatic) were meta-analyzed. Thirty-day DSM was 1.30% vs. 4.11% (p < 0.01, data for SGS vs. FGS). Among SGS, both Casper/Roadsaver and CGuard reduced 30-day DSM (by 2.78 and 3.03 absolute percent, p = 0.02 and p < 0.001), whereas the Gore stent was neutral. SGSs significantly improved outcomes compared with closed-cell FGS (30-day stroke 0.6% vs. 2.32%, p = 0.014; DSM 1.3% vs. 3.15%, p < 0.01). At 12 months, in relation to FGS, Casper/Roadsaver reduced IS (−3.25%, p < 0.05) but increased ISR (+3.19%, p = 0.04), CGuard showed a reduction in both IS and ISR (−3.13%, −3.63%; p = 0.01, p < 0.01), whereas the Gore stent was neutral. Conclusions: Pooled SGS use was associated with improved short- and long-term clinical results of CAS. Individual SGS types, however, differed significantly in their outcomes, indicating a lack of a “mesh stent” class effect. Findings from this meta-analysis may provide clinically relevant information in anticipation of large-scale randomized trials.

21 August 2023 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
LTLukasz Tekieli
Lukasz Tekieli
AKAnna Kablak-Ziembicka
Anna Kablak-Ziembicka
WDWladyslaw Dabrowski
Wladyslaw Dabrowski
KDKarolina Dzierwa
Karolina Dzierwa
ZMZbigniew Moczulski
Zbigniew Moczulski
PMPiotr Musiałek
Piotr Musiałek
Purpose: Different non-invasive and invasive imaging modalities are used to determine carotid artery stenosis severity that remains a principal parameter in clinical decision-making. We compared stenosis degree obtained with different modalities against vascular imaging gold standard, intravascular ultrasound, IVUS. Methods: 300 consecutive patients (age 47–83 years, 192 men, 64% asymptomatic) with carotid artery stenosis of “ ≥ 50%” referred for potential revascularization received as per study protocol (i) duplex ultrasound (DUS), (ii) computed tomography angiography (CTA), (iii) intraarterial quantitative angiography (iQA) and (iv) and (iv) IVUS. Correlation of measurements with IVUS (r), proportion of those concordant (within 10%) and proportion of under/overestimated were calculated along with recipient-operating-characteristics (ROC). Results: For IVUS area stenosis (AS) and IVUS minimal lumen area (MLA), there was only a moderate correlation with DUS velocities (peak-systolic, PSV; end-diastolic, EDV; r values of 0.42–0.51, p < 0.001 for all). CTA systematically underestimated both reference area and MLA (80.4% and 92.3% cases) but CTA error was lesser for AS (proportion concordant-57.4%; CTA under/overestimation-12.5%/30.1%). iQA diameter stenosis (DS) was found concordant with IVUS in 41.1% measurements (iQA under/overestimation 7.9%/51.0%). By univariate model, PSV (ROC area-under-the-curve, AUC, 0.77, cutoff 2.6 m/s), EDV (AUC 0.72, cutoff 0.71 m/s) and CTA-DS (AUC 0.83, cutoff 59.6%) were predictors of ≥ 50% DS by IVUS (p < 0.001 for all). Best predictor, however, of ≥ 50% DS by IVUS was stenosis severity evaluation by automated contrast column density measurement on iQA (AUC 0.87, cutoff 68%, p < 0.001). Regarding non-invasive techniques, CTA was the only independent diagnostic modality against IVUS on multivariate model (p = 0.008). Conclusion: IVUS validation shows significant imaging modality-dependent variations in carotid stenosis severity determination.

1 July 2024 in The Journal of Cardiovascular Surgery
Verified
Journal Article
Closed access
LTLukasz Tekieli
Lukasz Tekieli
KDKarolina Dzierwa
Karolina Dzierwa
IGIris Q. Grunwald
Iris Q. Grunwald
AMAdam Mazurek
Adam Mazurek
MUMalgorzata Urbanczyk-Zawadzka
Malgorzata Urbanczyk-Zawadzka
PMPiotr Musialek
Piotr Musialek
Article: Outcomes in acute carotid-related stroke eligible for mechanical reperfusion: SAFEGUARD-STROKE Registry - The Journal of Cardiovascular Surgery 2024 June;65(3):231-48 - Minerva Medica - Journals

30 November 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
LTLukasz Tekieli
Lukasz Tekieli
AMAdam Mazurek
Adam Mazurek
PPPiotr Pieniazek
Piotr Pieniazek
PMPiotr Musiałek
Piotr Musiałek
Background: Restenosis in first-generation (single-layer) carotid stents (FGS) is believed to represent an exaggerated healing response of (neo)intimal hyperplasia (NIH) formation. Rather than NIH, we describe symptomatic in-FGS unstable plaque (neo)atherosclerosis mandating re-revascularization. To halt continued plaque evolution, we propose a novel treatment strategy involving a microNet-covered stent (MCS, second-generation carotid stent) to sequestrate the plaque from the vessel lumen. A durable long-term result is documented using multi-modal imaging. Case summary: With a seemingly optimal result of FGS (Precise) symptomatic carotid lesion revascularization followed by optimal medical therapy, a late (≥3 years) progressive in-stent restenosis (ISR) arose. At Year 11, crescendo ipsilateral transient ischaemic attacks occurred. Angiography showed an ulcerated tight lesion throughout stent length. Intravascular ultrasound (IVUS) virtual histology imaging revealed thin-cap fibroatheroma. Reintervention was performed under distal protection. Undersized balloon predilatation to insert a stent caused symptomatic no-flow, and aspiration catheter was used to reduce the filter load. A MCS (CGuard) was implanted and post-dilated to ensure full lumen gain; IVUS confirmed complete plaque sequestration. The optimal anatomic result remained unchanged throughout 5 years (ultrasound and computed tomography verification); this was accompanied by clinical cure. Discussion: This is the first demonstration of in-FGS (neo)atherosclerosis resolution using an MCS to sequestrate and insulate the atherosclerotic plaque. We show that ISR may be underlined by atherosclerotic plaque progression via the FGS single-layer stent struts that may show vulnerable plaque phenotype and may be associated with cerebral ischaemia. The anatomically and clinically effective exclusion of the atherosclerotic plaque by an MCS enabled lasting, optimal endovascular reconstruction and clinical cure.

8 February 2023 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
AAAsger Andersen
Asger Andersen
PMPiotr Musialek
Piotr Musialek
AAAleksander Araszkiewicz
Aleksander Araszkiewicz
JSJacob Schultz
Jacob Schultz
JNJens Erik Nielsen-Kudsk
Jens Erik Nielsen-Kudsk
IWIdo Weinberg
Ido Weinberg

1 January 2024 in Advances in Interventional Cardiology
Verified
Journal Article
Open access
LTLukasz Tekieli
Lukasz Tekieli
AAAndrey Afanasiev
Andrey Afanasiev
MMMaciej Mazgaj
Maciej Mazgaj
VBVladimir Borodetsky
Vladimir Borodetsky
KSKolja Sievert
Kolja Sievert
AAAndrej Afanasjev
Andrej Afanasjev
Introduction Acute carotid-related stroke (CRS), with its large thrombo-embolic load and large volume of affected brain tissue, poses significant management challenges. First generation (single-layer) carotid stents fail to insulate the atherothrombotic material; thus they are often...